3l2a
From Proteopedia
Line 1: | Line 1: | ||
- | {{Seed}} | ||
- | [[Image:3l2a.png|left|200px]] | ||
- | |||
- | <!-- | ||
- | The line below this paragraph, containing "STRUCTURE_3l2a", creates the "Structure Box" on the page. | ||
- | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
- | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
- | or leave the SCENE parameter empty for the default display. | ||
- | --> | ||
{{STRUCTURE_3l2a| PDB=3l2a | SCENE= }} | {{STRUCTURE_3l2a| PDB=3l2a | SCENE= }} | ||
- | |||
===Crystal structure of Reston Ebola VP35 interferon inhibitory domain=== | ===Crystal structure of Reston Ebola VP35 interferon inhibitory domain=== | ||
+ | {{ABSTRACT_PUBMED_20399790}} | ||
- | + | ==Function== | |
- | + | [[http://www.uniprot.org/uniprot/VP35_EBORR VP35_EBORR]] Acts as a polymerase cofactor in the RNA polymerase transcription and replication complex. Prevents establishment of cellular antiviral state by blocking virus-induced phosphorylation and activation of interferon regulatory factor 3 (IRF3), a transcription factor critical for the induction of interferons alpha and beta. The mechanism by which this blockage occurs remains incompletely defined, a hypothesis suggests that VP35 dsRNA-binding activity prevents activation of IRF3 by sequestering dsRNA. Also inhibits the antiviral effect mediated by the interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2/PKR (By similarity). | |
- | + | ||
- | + | ||
- | -- | + | |
- | + | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[3l2a]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Reston_ebolavirus Reston ebolavirus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3L2A OCA]. | |
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:020399790</ref><references group="xtra"/><references/> |
[[Category: Reston ebolavirus]] | [[Category: Reston ebolavirus]] | ||
[[Category: Amarasinghe, G K.]] | [[Category: Amarasinghe, G K.]] | ||
Line 40: | Line 27: | ||
[[Category: Transcription]] | [[Category: Transcription]] | ||
[[Category: Virion]] | [[Category: Virion]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 18 11:03:44 2010'' |
Revision as of 20:02, 4 April 2013
Contents |
Crystal structure of Reston Ebola VP35 interferon inhibitory domain
Template:ABSTRACT PUBMED 20399790
Function
[VP35_EBORR] Acts as a polymerase cofactor in the RNA polymerase transcription and replication complex. Prevents establishment of cellular antiviral state by blocking virus-induced phosphorylation and activation of interferon regulatory factor 3 (IRF3), a transcription factor critical for the induction of interferons alpha and beta. The mechanism by which this blockage occurs remains incompletely defined, a hypothesis suggests that VP35 dsRNA-binding activity prevents activation of IRF3 by sequestering dsRNA. Also inhibits the antiviral effect mediated by the interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2/PKR (By similarity).
About this Structure
3l2a is a 1 chain structure with sequence from Reston ebolavirus. Full crystallographic information is available from OCA.
Reference
- Leung DW, Shabman RS, Farahbakhsh M, Prins KC, Borek DM, Wang T, Muhlberger E, Basler CF, Amarasinghe GK. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J Mol Biol. 2010 Jun 11;399(3):347-57. Epub 2010 Apr 24. PMID:20399790 doi:10.1016/j.jmb.2010.04.022
Categories: Reston ebolavirus | Amarasinghe, G K. | Basler, C F. | Borek, D M. | Farahbakhsh, M. | Leung, D W. | Prins, K C. | Host cytoplasm | Interferon antiviral evasion | Interferon antiviral system evasion | Rna binding domain | Rna binding protein | Rna replication | Rna-binding | Transcription | Virion